GLP-1(32-36)amide Pentapeptide Increases Basal Energy Expenditure and Inhibits Weight Gain in Obese Mice

The prevalence of obesity-related diabetes is increasing worldwide. Here we report the identification of a pentapeptide, GLP-1(32-36)amide (LVKGRamide), derived from the glucoincretin hormone GLP-1, that increases basal energy expenditure and curtails the development of obesity, insulin resistance,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomas, Eva, Stanojevic, Violeta, McManus, Karen, Khatri, Ashok, Everill, Paul, Bachovchin, William W., Habener, Joel F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2015
Materias:
Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477344/
https://www.ncbi.nlm.nih.gov/pubmed/25858562
http://dx.doi.org/10.2337/db14-1708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477344/
https://www.ncbi.nlm.nih.gov/pubmed/25858562
http://dx.doi.org/10.2337/db14-1708

Ejemplares similares